| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.598 | 0.002 | 0.598 | Protocollagen prolyl hydroxylase inhibitor | 0.222 0.003 DBMET03602 0.189 0.003 DBMET03604 0.189 0.003 DBMET03606 0.367 0.002 DBMET03607 0.195 0.003 DBMET03603 0.189 0.003 DBMET03605 | ||
| 0.422 | 0.012 | 0.44 | Sodium/bile acid cotransporter inhibitor | 0.433 0.01 DBMET03602 0.424 0.011 DBMET03604 0.424 0.011 DBMET03606 0.44 0.009 DBMET03607 0.422 0.012 DBMET03603 0.424 0.011 DBMET03605 | DBMET03607 | |
| 0.4 | 0.021 | 0.501 | DNA synthesis inhibitor | 0.501 0.013 DBMET03602 0.46 0.016 DBMET03604 0.46 0.016 DBMET03606 0.445 0.017 DBMET03607 0.476 0.015 DBMET03603 0.46 0.016 DBMET03605 | DBMET03602 | |
| 0.412 | 0.056 | 0.499 | Toll-Like receptor agonist | 0.343 0.086 DBMET03602 0.381 0.068 DBMET03604 0.381 0.068 DBMET03606 0.499 0.032 DBMET03607 0.336 0.09 DBMET03603 0.381 0.068 DBMET03605 | DBMET03607 | |
| 0.409 | 0.056 | 0.499 | Toll-Like receptor 7 agonist | 0.343 0.085 DBMET03602 0.381 0.068 DBMET03604 0.381 0.068 DBMET03606 0.499 0.032 DBMET03607 0.336 0.089 DBMET03603 0.381 0.068 DBMET03605 | DBMET03607 | |
| 0.381 | 0.031 | 0.381 | Platelet antagonist | 0.33 0.043 DBMET03602 0.329 0.044 DBMET03604 0.329 0.044 DBMET03606 0.381 0.031 DBMET03607 0.343 0.04 DBMET03603 0.329 0.044 DBMET03605 | ||
| 0.34 | 0.013 | 0.34 | NOS3 expression enhancer | 0.314 0.016 DBMET03602 0.291 0.019 DBMET03604 0.291 0.019 DBMET03606 0.335 0.013 DBMET03607 0.34 0.013 DBMET03603 0.291 0.019 DBMET03605 | ||
| 0.342 | 0.017 | 0.476 | Diuretic | 0.457 0.01 DBMET03602 0.456 0.01 DBMET03604 0.456 0.01 DBMET03606 0.303 0.022 DBMET03607 0.476 0.009 DBMET03603 0.456 0.01 DBMET03605 | DBMET03603 | |
| 0.383 | 0.085 | 0.528 | Antibacterial | 0.521 0.035 DBMET03602 0.489 0.044 DBMET03604 0.489 0.044 DBMET03606 0.444 0.059 DBMET03607 0.528 0.033 DBMET03603 0.489 0.044 DBMET03605 | DBMET03603 | |
| 0.307 | 0.028 | 0.307 | Gastrin inhibitor | 0.217 0.123 DBMET03602 0.195 0.157 DBMET03604 0.195 0.157 DBMET03606 0.268 0.06 DBMET03607 0.195 0.157 DBMET03605 | ||
| 0.293 | 0.027 | 0.35 | Peptidyltransferase inhibitor | 0.341 0.014 DBMET03602 0.327 0.017 DBMET03604 0.327 0.017 DBMET03606 0.326 0.017 DBMET03607 0.35 0.012 DBMET03603 0.327 0.017 DBMET03605 | DBMET03603 | |
| 0.267 | 0.013 | 0.267 | Cell adhesion inhibitor | 0.177 0.032 DBMET03602 0.173 0.034 DBMET03604 0.173 0.034 DBMET03606 0.239 0.016 DBMET03607 0.178 0.032 DBMET03603 0.173 0.034 DBMET03605 | ||
| 0.326 | 0.074 | 0.378 | Antithrombotic | 0.344 0.066 DBMET03602 0.343 0.067 DBMET03604 0.343 0.067 DBMET03606 0.378 0.055 DBMET03607 0.304 0.085 DBMET03603 0.343 0.067 DBMET03605 | DBMET03607 | |
| 0.233 | 0.015 | 0.233 | GABA C receptor agonist | 0.097 0.07 DBMET03602 0.11 0.057 DBMET03607 | ||
| 0.269 | 0.052 | 0.269 | Tyrosine 3 hydroxylase inhibitor | 0.182 0.172 DBMET03607 | ||
| 0.24 | 0.025 | 0.24 | Alpha-N-acetylglucosaminidase inhibitor | 0.209 0.032 DBMET03602 0.161 0.049 DBMET03604 0.161 0.049 DBMET03606 0.237 0.025 DBMET03607 0.161 0.049 DBMET03603 0.161 0.049 DBMET03605 | ||
| 0.291 | 0.08 | 0.363 | Interleukin 2 agonist | 0.348 0.046 DBMET03602 0.334 0.053 DBMET03604 0.334 0.053 DBMET03606 0.363 0.04 DBMET03607 0.33 0.055 DBMET03603 0.334 0.053 DBMET03605 | DBMET03607 | |
| 0.214 | 0.005 | 0.214 | Smo receptor antagonist | 0.067 0.016 DBMET03602 0.051 0.023 DBMET03604 0.051 0.023 DBMET03606 0.086 0.01 DBMET03607 0.044 0.027 DBMET03603 0.051 0.023 DBMET03605 | ||
| 0.208 | 0.009 | 0.208 | Cell adhesion molecule inhibitor | 0.112 0.027 DBMET03602 0.11 0.028 DBMET03604 0.11 0.028 DBMET03606 0.162 0.013 DBMET03607 0.101 0.034 DBMET03603 0.11 0.028 DBMET03605 | ||
| 0.217 | 0.03 | 0.217 | Topoisomerase II inhibitor | 0.176 0.039 DBMET03607 | ||
| 0.326 | 0.141 | 0.416 | Cyclophilin D inhibitor | 0.316 0.149 DBMET03602 0.309 0.155 DBMET03604 0.309 0.155 DBMET03606 0.416 0.082 DBMET03607 0.334 0.134 DBMET03603 0.309 0.155 DBMET03605 | DBMET03607 | |
| 0.266 | 0.083 | 0.266 | Insulysin inhibitor | |||
| 0.223 | 0.046 | 0.223 | Anticoagulant | 0.217 0.047 DBMET03602 0.205 0.051 DBMET03604 0.205 0.051 DBMET03606 0.181 0.061 DBMET03607 0.194 0.055 DBMET03603 0.205 0.051 DBMET03605 | ||
| 0.241 | 0.081 | 0.241 | Superoxide dismutase inhibitor | 0.182 0.138 DBMET03607 | ||
| 0.244 | 0.087 | 0.244 | 5 Hydroxytryptamine uptake stimulant | 0.22 0.117 DBMET03607 | ||
| 0.15 | 0.003 | 0.15 | Phospholipase D inhibitor | 0.135 0.004 DBMET03602 0.12 0.006 DBMET03604 0.12 0.006 DBMET03606 0.143 0.004 DBMET03607 0.119 0.007 DBMET03603 0.12 0.006 DBMET03605 | ||
| 0.274 | 0.139 | 0.274 | Histamine release inhibitor | |||
| 0.174 | 0.044 | 0.23 | Cell wall synthesis inhibitor | 0.217 0.024 DBMET03602 0.223 0.022 DBMET03604 0.223 0.022 DBMET03606 0.177 0.042 DBMET03607 0.23 0.02 DBMET03603 0.223 0.022 DBMET03605 | DBMET03603 | |
| 0.146 | 0.021 | 0.157 | Electrolyte absorption antagonist | 0.157 0.017 DBMET03602 0.137 0.025 DBMET03604 0.137 0.025 DBMET03606 0.124 0.033 DBMET03603 0.137 0.025 DBMET03605 | DBMET03602 | |
| 0.249 | 0.129 | 0.327 | Apoptosis antagonist | 0.327 0.068 DBMET03602 0.3 0.085 DBMET03604 0.3 0.085 DBMET03606 0.282 0.098 DBMET03607 0.309 0.08 DBMET03603 0.3 0.085 DBMET03605 | DBMET03602 | |
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | |||
| 0.143 | 0.036 | 0.19 | Mucolytic | 0.16 0.027 DBMET03602 0.159 0.027 DBMET03604 0.159 0.027 DBMET03606 0.19 0.016 DBMET03607 0.151 0.032 DBMET03603 0.159 0.027 DBMET03605 | DBMET03607 | |
| 0.172 | 0.067 | 0.193 | Thrombolytic | 0.144 0.086 DBMET03602 0.148 0.084 DBMET03604 0.148 0.084 DBMET03606 0.193 0.055 DBMET03607 0.132 0.097 DBMET03603 0.148 0.084 DBMET03605 | DBMET03607 | |
| 0.196 | 0.097 | 0.311 | Hypolipemic | 0.311 0.046 DBMET03602 0.284 0.054 DBMET03604 0.284 0.054 DBMET03606 0.281 0.055 DBMET03607 0.283 0.054 DBMET03603 0.284 0.054 DBMET03605 | DBMET03602 | |
| 0.1 | 0.004 | 0.1 | Membrane dipeptidase inhibitor | 0.063 0.009 DBMET03602 0.059 0.011 DBMET03604 0.059 0.011 DBMET03606 0.059 0.01 DBMET03607 0.052 0.014 DBMET03603 0.059 0.011 DBMET03605 | ||
| 0.207 | 0.116 | 0.3 | Immunostimulant | 0.266 0.09 DBMET03602 0.251 0.096 DBMET03604 0.251 0.096 DBMET03606 0.3 0.078 DBMET03607 0.283 0.084 DBMET03603 0.251 0.096 DBMET03605 | DBMET03607 | |
| 0.14 | 0.052 | 0.233 | Adenylate cyclase inhibitor | 0.168 0.035 DBMET03602 0.188 0.028 DBMET03604 0.188 0.028 DBMET03606 0.233 0.021 DBMET03607 0.158 0.04 DBMET03603 0.188 0.028 DBMET03605 | DBMET03607 | |
| 0.226 | 0.143 | 0.311 | Cholesterol antagonist | 0.277 0.107 DBMET03602 0.239 0.134 DBMET03604 0.239 0.134 DBMET03606 0.311 0.084 DBMET03607 0.201 0.164 DBMET03603 0.239 0.134 DBMET03605 | DBMET03607 | |
| 0.086 | 0.003 | 0.086 | Egl nine homolog 2 inhibitor | 0.051 0.004 DBMET03602 0.043 0.004 DBMET03604 0.043 0.004 DBMET03606 0.058 0.003 DBMET03607 0.041 0.004 DBMET03603 0.043 0.004 DBMET03605 | ||
| 0.12 | 0.038 | 0.12 | Prolactin inhibitor | |||
| 0.102 | 0.024 | 0.102 | Epoxide hydrolase inhibitor | 0.095 0.028 DBMET03607 | ||
| 0.091 | 0.018 | 0.154 | Androgen agonist | 0.109 0.012 DBMET03602 0.114 0.011 DBMET03604 0.114 0.011 DBMET03606 0.154 0.007 DBMET03607 0.12 0.01 DBMET03603 0.114 0.011 DBMET03605 | DBMET03607 | |
| 0.088 | 0.02 | 0.088 | GP IIb/IIIa receptor antagonist | 0.048 0.034 DBMET03607 | ||
| 0.166 | 0.103 | 0.298 | Psychostimulant | 0.248 0.059 DBMET03602 0.298 0.043 DBMET03604 0.298 0.043 DBMET03606 0.199 0.08 DBMET03607 0.234 0.065 DBMET03603 0.298 0.043 DBMET03605 | DBMET03605 | |
| 0.09 | 0.028 | 0.117 | Glycine receptor agonist | 0.097 0.022 DBMET03602 0.084 0.034 DBMET03604 0.084 0.034 DBMET03606 0.117 0.014 DBMET03607 0.079 0.04 DBMET03603 0.084 0.034 DBMET03605 | DBMET03607 | |
| 0.075 | 0.016 | 0.075 | CC chemokine 5 receptor antagonist | 0.049 0.038 DBMET03607 | ||
| 0.114 | 0.055 | 0.183 | Expectorant | 0.143 0.038 DBMET03602 0.142 0.039 DBMET03604 0.142 0.039 DBMET03606 0.183 0.024 DBMET03607 0.16 0.032 DBMET03603 0.142 0.039 DBMET03605 | DBMET03607 | |
| 0.092 | 0.035 | 0.092 | Glutamate dehydrogenase inhibitor | 0.086 0.04 DBMET03602 0.069 0.058 DBMET03604 0.069 0.058 DBMET03606 0.078 0.047 DBMET03607 0.069 0.058 DBMET03603 0.069 0.058 DBMET03605 | ||
| 0.09 | 0.034 | 0.09 | Aminopeptidase I inhibitor | 0.064 0.063 DBMET03607 | ||
| 0.167 | 0.112 | 0.267 | Angiogenesis stimulant | 0.204 0.093 DBMET03602 0.221 0.084 DBMET03604 0.221 0.084 DBMET03606 0.267 0.062 DBMET03607 0.207 0.091 DBMET03603 0.221 0.084 DBMET03605 | DBMET03607 | |
| 0.186 | 0.132 | 0.258 | Spasmolytic | 0.204 0.116 DBMET03604 0.204 0.116 DBMET03606 0.258 0.088 DBMET03607 0.204 0.116 DBMET03605 | DBMET03607 | |
| 0.077 | 0.03 | 0.081 | Carbamoyl phosphate synthetase inhibitor | 0.081 0.028 DBMET03602 0.063 0.04 DBMET03604 0.063 0.04 DBMET03606 0.072 0.033 DBMET03607 0.063 0.04 DBMET03603 0.063 0.04 DBMET03605 | DBMET03602 | |
| 0.109 | 0.065 | 0.109 | Chelator | 0.1 0.078 DBMET03607 | ||
| 0.061 | 0.017 | 0.061 | Erythropoietin receptor agonist | 0.038 0.03 DBMET03602 0.041 0.028 DBMET03607 | ||
| 0.121 | 0.078 | 0.121 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 DBMET03602 0.115 0.094 DBMET03607 | ||
| 0.064 | 0.022 | 0.116 | Alpha-mannosidase inhibitor | 0.116 0.005 DBMET03602 0.095 0.007 DBMET03604 0.095 0.007 DBMET03606 0.077 0.013 DBMET03607 0.092 0.008 DBMET03603 0.095 0.007 DBMET03605 | DBMET03602 | |
| 0.149 | 0.107 | 0.183 | Phospholipase C inhibitor | 0.175 0.067 DBMET03602 0.158 0.09 DBMET03604 0.158 0.09 DBMET03606 0.183 0.058 DBMET03607 0.17 0.072 DBMET03603 0.158 0.09 DBMET03605 | DBMET03607 | |
| 0.05 | 0.008 | 0.05 | Integrin alpha1beta1 antagonist | 0.037 0.03 DBMET03602 0.039 0.024 DBMET03607 | ||
| 0.047 | 0.006 | 0.048 | LFA antagonist | 0.027 0.02 DBMET03602 0.026 0.022 DBMET03604 0.026 0.022 DBMET03606 0.048 0.006 DBMET03607 0.025 0.024 DBMET03603 0.026 0.022 DBMET03605 | DBMET03607 | |
| 0.092 | 0.05 | 0.122 | Acetylcholine M3 receptor agonist | 0.078 0.062 DBMET03602 0.093 0.05 DBMET03604 0.093 0.05 DBMET03606 0.122 0.033 DBMET03607 0.081 0.059 DBMET03603 0.093 0.05 DBMET03605 | DBMET03607 | |
| 0.122 | 0.082 | 0.122 | Vanilloid 1 agonist | |||
| 0.046 | 0.006 | 0.046 | Nociceptin (N/OFQ) receptor agonist | 0.025 0.012 DBMET03607 | ||
| 0.082 | 0.042 | 0.082 | Glutamate decarboxylase inhibitor | |||
| 0.07 | 0.03 | 0.07 | Argininosuccinate synthase inhibitor | 0.054 0.042 DBMET03602 0.05 0.047 DBMET03604 0.05 0.047 DBMET03606 0.058 0.038 DBMET03607 0.05 0.047 DBMET03605 | ||
| 0.147 | 0.108 | 0.147 | Neurotensin receptor agonist | |||
| 0.041 | 0.005 | 0.041 | Glutamate (mGluR1) agonist | |||
| 0.057 | 0.021 | 0.057 | Cholecystokinin antagonist | |||
| 0.04 | 0.005 | 0.04 | Glutamate (mGluR1a) agonist | |||
| 0.09 | 0.056 | 0.094 | NADH dehydrogenase inhibitor | 0.094 0.051 DBMET03602 0.079 0.077 DBMET03604 0.079 0.077 DBMET03606 0.087 0.062 DBMET03607 0.079 0.077 DBMET03603 0.079 0.077 DBMET03605 | DBMET03602 | |
| 0.037 | 0.003 | 0.037 | Egl nine homolog 3 inhibitor | 0.012 0.009 DBMET03607 | ||
| 0.042 | 0.01 | 0.042 | Adenosine uptake inhibitor | |||
| 0.035 | 0.004 | 0.035 | Egl nine homolog 1 inhibitor | |||
| 0.041 | 0.01 | 0.041 | Lysine carboxypeptidase inhibitor | |||
| 0.048 | 0.017 | 0.048 | Kainate receptor agonist | 0.039 0.035 DBMET03607 | ||
| 0.077 | 0.046 | 0.077 | Cathepsin G inhibitor | |||
| 0.086 | 0.056 | 0.086 | Hematopoietic | 0.079 0.075 DBMET03602 0.079 0.075 DBMET03607 | ||
| 0.057 | 0.027 | 0.057 | Glycine transporter 2 inhibitor | |||
| 0.055 | 0.025 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 DBMET03604 0.05 0.032 DBMET03606 0.056 0.025 DBMET03607 0.05 0.032 DBMET03605 | DBMET03607 | |
| 0.042 | 0.012 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.033 0.032 DBMET03607 | ||
| 0.06 | 0.031 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.053 0.037 DBMET03602 0.048 0.042 DBMET03607 | ||
| 0.098 | 0.07 | 0.101 | Adenylate kinase inhibitor | 0.101 0.066 DBMET03602 0.093 0.08 DBMET03607 | DBMET03602 | |
| 0.088 | 0.059 | 0.088 | Opioid antagonist | 0.086 0.061 DBMET03607 | ||
| 0.059 | 0.032 | 0.059 | Angiotensin-converting enzyme inhibitor | 0.051 0.046 DBMET03607 | ||
| 0.045 | 0.018 | 0.045 | Arginase inhibitor | 0.033 0.028 DBMET03607 | ||
| 0.129 | 0.105 | 0.145 | Adenylate cyclase stimulant | 0.138 0.085 DBMET03602 0.128 0.106 DBMET03604 0.128 0.106 DBMET03606 0.145 0.071 DBMET03607 0.128 0.106 DBMET03605 | DBMET03607 | |
| 0.095 | 0.072 | 0.095 | Glutamate (mGluR7) agonist | |||
| 0.087 | 0.064 | 0.087 | Phosphodiesterase I inhibitor | |||
| 0.089 | 0.067 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.215 | 0.193 | 0.281 | Antiobesity | 0.281 0.13 DBMET03607 | DBMET03607 | |
| 0.036 | 0.017 | 0.036 | Carboxypeptidase B inhibitor | |||
| 0.044 | 0.025 | 0.061 | Thymidine kinase inhibitor | 0.061 0.013 DBMET03602 0.061 0.013 DBMET03604 0.061 0.013 DBMET03606 0.059 0.014 DBMET03607 0.058 0.014 DBMET03603 0.061 0.013 DBMET03605 | DBMET03605 | |
| 0.047 | 0.029 | 0.097 | Mannosidase inhibitor | 0.097 0.006 DBMET03602 0.078 0.009 DBMET03604 0.078 0.009 DBMET03606 0.06 0.017 DBMET03607 0.076 0.01 DBMET03603 0.078 0.009 DBMET03605 | DBMET03602 | |
| 0.032 | 0.015 | 0.032 | Vasopressin 1B antagonist | 0.024 0.023 DBMET03607 | ||
| 0.039 | 0.022 | 0.039 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.034 | 0.018 | 0.034 | Cholecystokinin B antagonist | |||
| 0.047 | 0.033 | 0.056 | Antimetabolite | 0.056 0.028 DBMET03602 0.043 0.038 DBMET03604 0.043 0.038 DBMET03606 0.051 0.031 DBMET03607 0.046 0.034 DBMET03603 0.043 0.038 DBMET03605 | DBMET03602 | |
| 0.02 | 0.008 | 0.02 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.042 | 0.03 | 0.042 | Integrin antagonist | |||
| 0.032 | 0.019 | 0.032 | Peptide deformylase inhibitor | |||
| 0.088 | 0.076 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.164 | 0.154 | 0.21 | Interleukin agonist | 0.198 0.122 DBMET03602 0.21 0.111 DBMET03607 | DBMET03607 | |
| 0.141 | 0.13 | 0.141 | Succinate dehydrogenase inhibitor | |||
| 0.094 | 0.084 | 0.094 | 5 Hydroxytryptamine 3A agonist | |||
| 0.041 | 0.032 | 0.041 | Leukocyte elastase inhibitor | |||
| 0.036 | 0.027 | 0.038 | 5-Alpha-reductase inhibitor | 0.038 0.026 DBMET03607 | DBMET03607 | |
| 0.05 | 0.042 | 0.071 | Elastase inhibitor | 0.071 0.021 DBMET03602 0.062 0.028 DBMET03604 0.062 0.028 DBMET03606 0.066 0.025 DBMET03603 0.062 0.028 DBMET03605 | DBMET03602 | |
| 0.072 | 0.063 | 0.072 | Metalloproteinase-2 inhibitor | |||
| 0.049 | 0.041 | 0.049 | Aconitate hydratase inhibitor | |||
| 0.049 | 0.042 | 0.049 | Phosphodiesterase 7A inhibitor | 0.049 0.043 DBMET03607 | ||
| 0.054 | 0.048 | 0.054 | Cannabinoid CB1 receptor agonist | |||
| 0.08 | 0.076 | 0.08 | Triose-phosphate isomerase inhibitor | |||
| 0.12 | 0.115 | 0.163 | Hemostatic | 0.156 0.061 DBMET03602 0.163 0.054 DBMET03604 0.163 0.054 DBMET03606 0.127 0.101 DBMET03607 0.16 0.056 DBMET03603 0.163 0.054 DBMET03605 | DBMET03605 | |
| 0.03 | 0.026 | 0.03 | Vasopressin 2 antagonist | |||
| 0.032 | 0.027 | 0.035 | RNA-directed RNA polymerase inhibitor | 0.035 0.022 DBMET03602 0.032 0.027 DBMET03604 0.032 0.027 DBMET03606 0.032 0.027 DBMET03605 | DBMET03602 | |
| 0.057 | 0.053 | 0.057 | NMDA receptor agonist | |||
| 0.033 | 0.029 | 0.033 | Cholecystokinin A antagonist | |||
| 0.015 | 0.012 | 0.017 | Thromboxane A2 agonist | 0.017 0.008 DBMET03607 | DBMET03607 | |
| 0.049 | 0.045 | 0.052 | Acetylcholine M2 receptor agonist | 0.052 0.04 DBMET03607 | DBMET03607 | |
| 0.012 | 0.009 | 0.014 | Integrin beta2 antagonist | 0.014 0.007 DBMET03607 | DBMET03607 | |
| 0.013 | 0.01 | 0.013 | Integrin alphaLbeta2 antagonist | 0.012 0.011 DBMET03607 | ||
| 0.087 | 0.084 | 0.116 | Anabolic | 0.105 0.055 DBMET03602 0.098 0.065 DBMET03604 0.098 0.065 DBMET03606 0.116 0.043 DBMET03607 0.104 0.058 DBMET03603 0.098 0.065 DBMET03605 | DBMET03607 | |
| 0.025 | 0.024 | 0.025 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.121 | 0.12 | 0.159 | Growth hormone agonist | 0.148 0.089 DBMET03602 0.13 0.107 DBMET03604 0.13 0.107 DBMET03606 0.159 0.08 DBMET03607 0.13 0.107 DBMET03603 0.13 0.107 DBMET03605 | DBMET03607 | |
| 0.024 | 0.03 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 DBMET03602 0.028 0.015 DBMET03604 0.028 0.015 DBMET03606 0.03 0.011 DBMET03607 0.027 0.018 DBMET03603 0.028 0.015 DBMET03605 | DBMET03607 | |
| 0.113 | 0.119 | 0.126 | Acetylcholine M1 receptor antagonist | 0.121 0.108 DBMET03604 0.121 0.108 DBMET03606 0.126 0.1 DBMET03607 0.121 0.108 DBMET03605 | DBMET03607 | |
| 0.069 | 0.076 | 0.078 | Glycine receptor antagonist | 0.074 0.066 DBMET03602 0.078 0.061 DBMET03607 | DBMET03607 | |
| 0.014 | 0.021 | 0.04 | Purinergic P2T antagonist | 0.022 0.015 DBMET03604 0.022 0.015 DBMET03606 0.026 0.013 DBMET03607 0.04 0.011 DBMET03603 0.022 0.015 DBMET03605 | DBMET03603 | |
| 0.024 | 0.034 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.025 DBMET03602 | DBMET03602 | |
| 0.017 | 0.028 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DBMET03602 0.02 0.016 DBMET03607 | DBMET03602 | |
| 0.066 | 0.083 | 0.075 | Opioid kappa receptor antagonist | 0.075 0.066 DBMET03607 | DBMET03607 | |
| 0.054 | 0.071 | 0.075 | Trypsin inhibitor | 0.075 0.03 DBMET03602 0.074 0.03 DBMET03604 0.074 0.03 DBMET03606 0.072 0.032 DBMET03603 0.074 0.03 DBMET03605 | DBMET03602 | |
| 0.021 | 0.04 | 0.04 | Trypsin I inhibitor | 0.04 0.017 DBMET03602 0.037 0.019 DBMET03604 0.037 0.019 DBMET03606 0.035 0.021 DBMET03603 0.037 0.019 DBMET03605 | DBMET03602 | |
| 0.057 | 0.076 | 0.068 | Thrombin inhibitor | 0.068 0.058 DBMET03602 0.067 0.059 DBMET03604 0.067 0.059 DBMET03606 0.067 0.059 DBMET03605 | DBMET03602 | |
| 0.085 | 0.105 | 0.142 | DNA polymerase I inhibitor | 0.142 0.054 DBMET03602 0.126 0.064 DBMET03604 0.126 0.064 DBMET03606 0.119 0.069 DBMET03607 0.122 0.066 DBMET03603 0.126 0.064 DBMET03605 | DBMET03602 | |
| 0.109 | 0.131 | 0.132 | Insulin secretagoues | 0.132 0.094 DBMET03607 | DBMET03607 | |
| 0.03 | 0.053 | 0.057 | Phosphorylase inhibitor | 0.057 0.026 DBMET03602 0.039 0.038 DBMET03604 0.039 0.038 DBMET03606 0.044 0.034 DBMET03607 0.052 0.029 DBMET03603 0.039 0.038 DBMET03605 | DBMET03602 | |
| 0.04 | 0.07 | 0.048 | Antiviral (Hepatitis D) | 0.048 0.042 DBMET03607 | DBMET03607 | |
| 0.062 | 0.093 | 0.096 | Chymotrypsin inhibitor | 0.096 0.039 DBMET03602 0.088 0.045 DBMET03604 0.088 0.045 DBMET03606 0.085 0.048 DBMET03603 0.088 0.045 DBMET03605 | DBMET03602 | |
| 0.12 | 0.164 | 0.168 | Lipocortins synthesis antagonist | 0.161 0.091 DBMET03602 0.145 0.113 DBMET03604 0.145 0.113 DBMET03606 0.168 0.083 DBMET03607 0.145 0.113 DBMET03603 0.145 0.113 DBMET03605 | DBMET03607 | |
| 0.11 | 0.161 | 0.135 | Interferon gamma antagonist | 0.135 0.1 DBMET03607 | DBMET03607 | |
| 0.076 | 0.127 | 0.173 | Alkylator | 0.171 0.037 DBMET03602 0.152 0.045 DBMET03604 0.152 0.045 DBMET03606 0.096 0.093 DBMET03607 0.173 0.036 DBMET03603 0.152 0.045 DBMET03605 | DBMET03603 | |
| 0.07 | 0.127 | 0.091 | Bile acid receptor antagonist | 0.091 0.07 DBMET03607 | DBMET03607 | |
| 0.033 | 0.094 | 0.046 | Parathyroid hormone antagonist | 0.046 0.028 DBMET03607 | DBMET03607 | |
| 0.098 | 0.162 | 0.135 | Farnesoid X receptor antagonist | 0.119 0.106 DBMET03602 0.135 0.073 DBMET03607 | DBMET03607 | |
| 0.025 | 0.099 | 0.051 | Plasmin inhibitor | 0.051 0.032 DBMET03602 0.045 0.034 DBMET03604 0.045 0.034 DBMET03606 0.043 0.036 DBMET03603 0.045 0.034 DBMET03605 | DBMET03602 | |
| 0.024 | 0.099 | 0.081 | Plasminogen activator inhibitor | 0.081 0.025 DBMET03602 0.077 0.027 DBMET03604 0.077 0.027 DBMET03606 0.071 0.031 DBMET03603 0.077 0.027 DBMET03605 | DBMET03602 | |
| 0.155 | 0.235 | 0.262 | Vasodilator, peripheral | 0.262 0.119 DBMET03602 0.218 0.156 DBMET03604 0.218 0.156 DBMET03606 0.218 0.156 DBMET03605 | DBMET03602 | |
| 0.069 | 0.158 | 0.105 | Microtubule formation inhibitor | 0.105 0.082 DBMET03602 | DBMET03602 | |
| 0.096 | 0.188 | 0.384 | Anesthetic general | 0.318 0.029 DBMET03602 0.35 0.024 DBMET03604 0.35 0.024 DBMET03606 0.185 0.083 DBMET03607 0.384 0.018 DBMET03603 0.35 0.024 DBMET03605 | DBMET03603 | |
| 0.018 | 0.117 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET03602 | DBMET03602 | |
| 0.024 | 0.129 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET03602 0.035 0.032 DBMET03604 0.035 0.032 DBMET03606 0.038 0.024 DBMET03607 0.035 0.033 DBMET03603 0.035 0.032 DBMET03605 | DBMET03607 | |
| 0.012 | 0.123 | 0.036 | Farnesoid X receptor agonist | 0.036 0.029 DBMET03607 | DBMET03607 | |
| 0.021 | 0.133 | 0.047 | Dopamine transporter inhibitor | 0.047 0.034 DBMET03607 | DBMET03607 | |
| 0.091 | 0.213 | 0.168 | Hepatoprotectant | 0.144 0.116 DBMET03602 0.143 0.118 DBMET03604 0.143 0.118 DBMET03606 0.168 0.091 DBMET03607 0.159 0.1 DBMET03603 0.143 0.118 DBMET03605 | DBMET03607 | |
| 0.194 | 0.33 | 0.268 | Caspase 9 stimulant | 0.268 0.231 DBMET03602 | DBMET03602 | |
| 0.02 | 0.16 | 0.06 | Protein 50S ribosomal subunit inhibitor | 0.051 0.039 DBMET03602 0.048 0.043 DBMET03604 0.048 0.043 DBMET03606 0.06 0.03 DBMET03603 0.048 0.043 DBMET03605 | DBMET03603 | |
| 0.129 | 0.282 | 0.248 | Immunomodulator | 0.221 0.141 DBMET03602 0.236 0.127 DBMET03604 0.236 0.127 DBMET03606 0.248 0.116 DBMET03607 0.245 0.119 DBMET03603 0.236 0.127 DBMET03605 | DBMET03607 | |
| 0.128 | 0.289 | 0.402 | Immunosuppressant | 0.308 0.11 DBMET03602 0.313 0.107 DBMET03604 0.313 0.107 DBMET03606 0.301 0.114 DBMET03607 0.402 0.062 DBMET03603 0.313 0.107 DBMET03605 | DBMET03603 | |
| 0.009 | 0.182 | 0.044 | 1,3-Beta-glucan synthase inhibitor | 0.04 0.004 DBMET03602 0.044 0.003 DBMET03604 0.044 0.003 DBMET03606 0.028 0.02 DBMET03607 0.044 0.003 DBMET03603 0.044 0.003 DBMET03605 | DBMET03605 | |
| 0.082 | 0.265 | 0.15 | Platelet aggregation inhibitor | 0.15 0.129 DBMET03602 0.143 0.137 DBMET03604 0.143 0.137 DBMET03606 0.145 0.135 DBMET03603 0.143 0.137 DBMET03605 | DBMET03602 | |
| 0.037 | 0.238 | 0.115 | Bronchodilator | 0.085 0.079 DBMET03602 0.113 0.05 DBMET03604 0.113 0.05 DBMET03606 0.115 0.048 DBMET03607 0.089 0.076 DBMET03603 0.113 0.05 DBMET03605 | DBMET03607 | |
| 0.082 | 0.29 | 0.182 | Vasodilator | 0.182 0.12 DBMET03602 0.18 0.122 DBMET03604 0.18 0.122 DBMET03606 0.17 0.131 DBMET03603 0.18 0.122 DBMET03605 | DBMET03602 | |
| 0.084 | 0.309 | 0.525 | Cardiotonic | 0.516 0.014 DBMET03602 0.507 0.014 DBMET03604 0.507 0.014 DBMET03606 0.174 0.146 DBMET03607 0.525 0.013 DBMET03603 0.507 0.014 DBMET03605 | DBMET03603 | |
| 0.009 | 0.284 | 0.102 | Antineoplastic antibiotic | 0.083 0.055 DBMET03602 0.079 0.058 DBMET03604 0.079 0.058 DBMET03606 0.102 0.045 DBMET03603 0.079 0.058 DBMET03605 | DBMET03603 | |
| 0.144 | 0.429 | 0.476 | Antiinflammatory | 0.47 0.101 DBMET03602 0.434 0.119 DBMET03604 0.434 0.119 DBMET03606 0.268 0.247 DBMET03607 0.476 0.098 DBMET03603 0.434 0.119 DBMET03605 | DBMET03603 | |
| 0.028 | 0.321 | 0.1 | Protein kinase C mu inhibitor | 0.1 0.057 DBMET03602 0.092 0.065 DBMET03604 0.092 0.065 DBMET03606 0.093 0.064 DBMET03603 0.092 0.065 DBMET03605 | DBMET03602 | |
| 0.03 | 0.73 | 0.197 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.197 0.161 DBMET03602 | DBMET03602 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |